YDR396W Antibody

What is YDR396W Antibody and what are its specifications?

YDR396W antibody (Product Code: CSB-PA519273XA01SVG) is a polyclonal antibody raised in rabbits against recombinant Saccharomyces cerevisiae (strain ATCC 204508/S288c) YDR396W protein. It is supplied in liquid form with a preservative of 0.03% Proclin 300 in a storage buffer consisting of 50% Glycerol and 0.01M PBS at pH 7.4. This antibody has been purified using antigen affinity methods, ensuring high specificity for the target protein .

The antibody recognizes the YDR396W protein from S. cerevisiae and has been specifically validated for ELISA and Western Blot applications. As with most research-grade antibodies, it is intended for research use only and not for diagnostic or therapeutic procedures .

What are the optimal storage conditions for YDR396W Antibody?

For maximum retention of antibody activity, YDR396W antibody should be stored at -20°C or -80°C immediately upon receipt. It is critical to avoid repeated freeze-thaw cycles as these can significantly reduce antibody functionality and increase background in experimental applications .

For researchers planning long-term studies, consider aliquoting the antibody into smaller working volumes before freezing to minimize freeze-thaw cycles. When handling the antibody:

What applications has YDR396W Antibody been validated for?

YDR396W antibody has been specifically validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) applications. When using this antibody for these methods, proper controls should be incorporated to ensure the correct identification of the target antigen .

For applications beyond ELISA and WB, researchers should perform their own validation studies to confirm antibody performance in their specific experimental system.

How should Western Blot protocols be optimized when using YDR396W Antibody?

When optimizing Western Blot protocols with YDR396W antibody, several parameters require careful consideration to obtain clear and specific signals:

Dilution Optimization:
Begin with a titration experiment using a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000) to determine the optimal antibody concentration that provides maximum specific signal with minimal background.

Blocking Conditions:
For yeast proteins, BSA-based blocking buffers (3-5%) often perform better than milk-based blockers, which can introduce cross-reactivity with certain yeast epitopes.

Sample Preparation Considerations:
Yeast cell walls require thorough disruption for complete protein extraction. Consider the following lysis protocol:

• Grow yeast cells to mid-log phase (OD600 ≈ 0.6-0.8)

• Harvest cells by centrifugation (3000×g, 5 minutes)

• Wash cell pellet with ice-cold PBS

• Resuspend in lysis buffer containing protease inhibitors

• Disrupt cells using glass beads or enzymatic methods

• Clarify lysate by centrifugation (14,000×g, 15 minutes, 4°C)

Optimization Table for Western Blotting:

What controls should be included when designing experiments with YDR396W Antibody?

Rigorous experimental design requires appropriate controls to ensure result validity and interpretability:

Positive Controls:

• Wild-type S. cerevisiae (strain ATCC 204508/S288c) expressing YDR396W

• Recombinant YDR396W protein (ideally the same immunogen used to generate the antibody)

Negative Controls:

• YDR396W knockout strain (if available)

• Non-target yeast species to assess cross-reactivity

• Secondary antibody-only control to detect non-specific binding

• Isotype control (non-targeting rabbit IgG) to identify potential non-specific signals

Validation Controls:

• Peptide competition assay: pre-incubate antibody with excess immunizing peptide to confirm signal specificity

• Multiple detection methods: confirm findings using orthogonal techniques (e.g., immunofluorescence, immunoprecipitation)

When analyzing data, statistical methods similar to those used in antibody characterization studies should be employed. For example, dose-response relationships can be modeled using four-parameter logistic (4PL) models as described in antibody characterization literature .

How can researchers troubleshoot inconsistent results with YDR396W Antibody in ELISA assays?

Inconsistent ELISA results with YDR396W antibody may stem from several sources. The following troubleshooting framework addresses common challenges:

Systematic Troubleshooting Approach:

• Antibody Activity Assessment:

  • Verify antibody hasn't degraded through improper storage

  • Test a new lot or aliquot of antibody

  • Consider using a known positive sample to validate antibody activity

• Protocol Optimization:

  • Antigen coating concentration (try 1-10 μg/mL range)

  • Blocking buffer composition (compare BSA vs. casein vs. commercial blockers)

  • Sample dilution series (perform broader ranges)

  • Incubation times and temperatures

  • Washing stringency (adjust number and duration of washes)

• Technical Variables:

  • Plate-to-plate variability (use high-binding ELISA plates)

  • Edge effects (avoid using outer wells or use plate sealers)

  • Temperature fluctuations during incubation

  • Pipetting precision (use calibrated multichannel pipettes)

Systematic Variation Analysis Table:

Using a methodical approach similar to that employed in antibody characterization studies, researchers should modify one variable at a time and document outcomes to identify optimal conditions .

What considerations are important for validating YDR396W Antibody specificity in different experimental systems?

Antibody validation is crucial for ensuring experimental reliability. For YDR396W antibody, consider these validation approaches:

Target Verification Methods:

• Genetic Approaches:

  • Test antibody reactivity in YDR396W knockout strains

  • Use strains with tagged YDR396W (e.g., epitope-tagged or fluorescent protein fusions)

  • Employ siRNA/CRISPR knockdown to confirm signal reduction correlates with reduced target expression

• Biochemical Validation:

  • Immunoprecipitation followed by mass spectrometry

  • Peptide array analysis to confirm epitope specificity

  • Multiple antibody approach (use antibodies targeting different epitopes)

• Orthogonal Techniques:

  • Compare protein expression using qRT-PCR for mRNA levels

  • Correlate with GFP-fusion protein localization

  • Use non-antibody detection methods where possible

Similar to antibody characterization approaches described in the literature, researchers should implement a systematic validation workflow that includes dose-response analysis and appropriate statistical methods to quantify antibody performance metrics .

How can researchers determine the optimal YDR396W Antibody concentration for specific experimental platforms?

Determining optimal antibody concentration requires systematic titration experiments across platforms:

Titration Strategy for Western Blot:

• Prepare a standard lysate from wild-type S. cerevisiae

• Prepare antibody dilutions (e.g., 1:500, 1:1000, 1:2000, 1:5000, 1:10000)

• Run identical blots with each antibody dilution

• Quantify signal-to-noise ratio for each dilution

• Select concentration with highest specific signal and lowest background

Titration Strategy for ELISA:

• Prepare a standard curve of recombinant target protein

• Test multiple antibody concentrations in a matrix format

• Calculate detection limits and linear range for each concentration

• Determine optimal concentration based on sensitivity needs and background levels

Concentration Optimization Data Analysis:

For quantitative analysis, researchers can employ statistical approaches similar to those used in antibody characterization studies, such as four-parameter logistic (4PL) models to determine the half-maximal effective concentration (EC50) of the antibody . The relationship between antibody dose and assay outcomes can be modeled using the formula:

y = L + (U − L)/(1 + (x/EC50)^h)

Where:

• L is the minimum signal (lower asymptote)

• U is the maximum signal (upper asymptote)

• EC50 is the concentration producing 50% of maximum signal

• h is the Hill slope determining curve steepness

What is known about the YDR396W gene and its protein product in S. cerevisiae?

YDR396W is a gene in Saccharomyces cerevisiae (Baker's yeast) that encodes a protein with UniProt accession number O13522 . While the search results don't provide extensive information about this specific gene's function, understanding its role typically requires:

• Phenotypic analysis of deletion mutants

• Localization studies using fluorescent protein fusions

• Protein interaction studies (Y2H, co-IP, BioID)

• Expression analysis under different growth conditions

• Evolutionary conservation analysis across fungal species

Researchers working with YDR396W antibody would benefit from integrating their antibody-based studies with these complementary approaches to build a comprehensive understanding of the protein's function.

How can researchers evaluate cross-reactivity of YDR396W Antibody with other yeast species?

Cross-reactivity assessment is essential for experiments involving multiple yeast species or strains:

Methodological Approach for Cross-Reactivity Testing:

• Prepare protein extracts from multiple species:

  • S. cerevisiae (positive control)

  • Closely related species (e.g., S. paradoxus, S. bayanus)

  • More distant species (e.g., Candida albicans, Schizosaccharomyces pombe)

• Run parallel Western blots or ELISAs with standardized protein amounts

• Quantify relative signal intensity across species

• Perform sequence alignment analysis:

  • Align YDR396W sequences across species

  • Identify conservation level of the immunogen region

  • Predict potential cross-reactivity based on epitope conservation

Cross-Reactivity Assessment Table:

Note: The sequence homology percentages provided are hypothetical examples - researchers should calculate actual values based on sequence alignments.

How can researchers incorporate YDR396W Antibody into multi-parameter assays for comprehensive protein analysis?

Multi-parameter approaches provide richer datasets for complex biological questions:

Integrated Experimental Approaches:

• Co-immunoprecipitation coupled with mass spectrometry:

  • Use YDR396W antibody for IP followed by MS to identify interaction partners

  • Compare interactome under different growth conditions or stress responses

  • Validate key interactions with reciprocal IP experiments

• ChIP-seq for potential DNA-binding activity:

  • If YDR396W has potential nuclear localization, chromatin immunoprecipitation using the antibody can identify potential DNA binding sites

  • Compare binding profiles under different conditions

• Multiplexed immunofluorescence:

  • Combine YDR396W antibody with markers for cellular compartments

  • Analyze co-localization under different conditions

  • Track changes in localization during the cell cycle or stress responses

What considerations are important when using YDR396W Antibody for time-course experiments?

Time-course experiments require special attention to consistency and reproducibility:

Experimental Design Considerations:

• Sample Collection and Processing:

  • Develop rapid sampling protocols to preserve time-point integrity

  • Consider flash-freezing samples if they cannot be processed immediately

  • Process all samples identically to minimize technical variation

• Antibody Batch Consistency:

  • Use the same antibody lot for the entire time course

  • Prepare sufficient working dilution for all time points at once

  • Include internal controls to normalize between blots/assays

• Quantification and Normalization:

  • Use digital image analysis for Western blots

  • Include loading controls appropriate for the experimental condition

  • Consider the half-life of the loading control protein

  • Normalize to total protein when studying conditions that affect housekeeping genes

• Statistical Analysis:

  • Apply time-series statistical methods rather than simple pairwise comparisons

  • Consider using statistical approaches like those described for antibody characterization studies, such as dose-response modeling and variance component analysis

What are the best practices for documenting YDR396W Antibody use in publications?

Proper documentation of antibody use is essential for reproducibility:

Publication Documentation Checklist:

• Antibody Specification Details:

  • Manufacturer and catalog number (CSB-PA519273XA01SVG)

  • Lot number used for experiments

  • Host species (Rabbit)

  • Clonality (Polyclonal)

  • Immunogen (Recombinant S. cerevisiae YDR396W protein)

• Validation Evidence:

  • Reference to previous validation studies

  • Description of validation performed in your system

  • Images of positive and negative controls

• Experimental Conditions:

  • Detailed protocol including dilutions, incubation times and temperatures

  • Buffer compositions

  • Detection methods and equipment settings

  • Quantification methods and software used

• Data Analysis:

  • Statistical methods used for quantification

  • Normalization approaches

  • Replicate structure (technical vs. biological)

Following these documentation practices aligns with the methodological rigor demonstrated in antibody characterization literature, ensuring experiment reproducibility and facilitating meta-analysis across studies .